The common mistake

Treating a model output like a final answer.

Core message: Scores without context, predictions without biology, and results without interpretation create fragile computational claims.

The mistake

The most common mistake in computational drug discovery is treating model output as the endpoint. A docking score becomes a binding claim. A predicted complex becomes a validated mechanism. A short MD run becomes proof of stability. This is not science; it is protocol-driven storytelling.

What outputs really are

Computational outputs are signals. Some are useful, some are misleading, and many are conditional on assumptions that are easy to forget. A score is a ranking heuristic. A pose is a structural hypothesis. A simulation is a dynamic experiment with finite sampling. An AI prediction is a learned estimate, not a biological fact.

What should happen instead

A good workflow forces interpretation. Why is this structure relevant? Why should this ligand state be used? Why is this pose plausible? What interactions persist? What alternative explanation exists? What claim is justified, and what claim is too strong?

Practical takeaway

Never move directly from output to conclusion. Insert an interpretation layer: context, plausibility, validation, uncertainty, and decision. That is where scientific quality is built.

How this connects to the cohort

The DeepDrug AI Summer Founding Cohort 2026 turns these principles into a practical workflow. Participants learn how to move from structure intelligence and ligand preparation to docking, AI-assisted scoring, pose validation, MD interpretation, and final decision logic. The objective is not to run more tools blindly. The objective is to make better scientific decisions.